These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1144478)

  • 1. Antagonism of morphine-induced aversive conditioning by naloxone.
    LeBlanc AE; Cappell H
    Pharmacol Biochem Behav; 1975; 3(2):185-8. PubMed ID: 1144478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal analysis of naloxone attenuation of morphine-induced taste aversion.
    Van der Kooy D; Phillips AG
    Pharmacol Biochem Behav; 1977 Jun; 6(6):637-41. PubMed ID: 263668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of drug discrimination learning within the conditioned taste aversion procedure.
    Stevenson GW; Pournaghash S; Riley AL
    Pharmacol Biochem Behav; 1992 Jan; 41(1):245-9. PubMed ID: 1539076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone, not proglumide or MK-801, alters effects of morphine preexposure on morphine-induced taste aversions.
    Fox MA; Stevenson GW; Rice KC; Riley AL
    Pharmacol Biochem Behav; 2006 May; 84(1):169-77. PubMed ID: 16777201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning.
    Parker LA; Cyr JA; Santi AN; Burton PD
    Pharmacol Biochem Behav; 2002 May; 72(1-2):87-92. PubMed ID: 11900773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioned taste aversion from neostigmine or methyl-naloxonium in the nucleus accumbens.
    Taylor KM; Mark GP; Hoebel BG
    Physiol Behav; 2011 Jul; 104(1):82-6. PubMed ID: 21549734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
    Sakoori K; Murphy NP
    Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioning tastant and the acquisition of conditioned taste avoidance to drugs of abuse in DBA/2J mice.
    Risinger FO; Boyce JM
    Psychopharmacology (Berl); 2002 Mar; 160(3):225-32. PubMed ID: 11889491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug reinforcement studied by the use of place conditioning in rat.
    Mucha RF; van der Kooy D; O'Shaughnessy M; Bucenieks P
    Brain Res; 1982 Jul; 243(1):91-105. PubMed ID: 6288174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone-induced taste aversions in opiate-naïve Lewis and Fischer 344 rat strains.
    Desko AG; Cobuzzi JL; Riley AL
    Drug Alcohol Depend; 2012 Apr; 122(1-2):152-5. PubMed ID: 21996495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of ethanol-induced conditioned taste aversion by naloxazone: behavioral evidence for an opiate receptor-mediated morphine-ethanol interaction.
    Ng Cheong Ton JM; Amit Z
    Neurosci Lett; 1984 Jul; 48(2):127-32. PubMed ID: 6090995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice.
    Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of SNC 80 and naltrindole within a conditioned taste aversion design.
    Hutchinson AC; Simpson GR; Randall JF; Zhang X; Calderon SN; Rice KC; Riley AL
    Pharmacol Biochem Behav; 2000 Aug; 66(4):779-87. PubMed ID: 10973516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aversive stimulus properties of morphine: evaluation using the drug preexposure conditioned taste aversion paradigm.
    Hunt T; Spivak K; Amit Z
    Behav Neural Biol; 1985 Jul; 44(1):60-73. PubMed ID: 3834923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion.
    Bardo MT; Miller JS; Risner ME
    Pharmacol Biochem Behav; 1984 Oct; 21(4):591-7. PubMed ID: 6095324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific enhancement of ethanol-induced taste aversion by naloxone.
    Miceli D; Marfaing-Jallat P; Le Magnen J
    Pharmacol Biochem Behav; 1979 Oct; 11(4):391-4. PubMed ID: 523497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heroin and morphine: aversive and analgesic effects in rats.
    Switzman L; Hunt T; Amit Z
    Pharmacol Biochem Behav; 1981 Nov; 15(5):755-9. PubMed ID: 7312910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
    Caillé S; Stinus L; Espejo EF; De Deurwaerdère P; Spampinato U; Koob GF
    Neuropsychopharmacology; 2003 Feb; 28(2):276-83. PubMed ID: 12589380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharin exposure increases the potency and aversive property of naloxone in drug-naive rats.
    Walker MJ; Leavitt B; Mucha RF
    Life Sci; 1988; 43(16):1305-11. PubMed ID: 3172982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.